{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cardiovascular disease", "Diabetes", "Dyslipidemia", "Lemon balm", "Melissa officinalis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30219475", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "02"}, "DateRevised": {"Year": "2019", "Month": "01", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "08", "Day": "03"}], "Language": ["eng"], "ELocationID": ["10.1016/j.ctim.2018.07.015", "S0965-2299(18)30355-8"], "Journal": {"ISSN": "1873-6963", "JournalIssue": {"Volume": "40", "PubDate": {"Year": "2018", "Month": "Oct"}}, "Title": "Complementary therapies in medicine", "ISOAbbreviation": "Complement Ther Med"}, "ArticleTitle": "Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: A randomized, double-blinded clinical trial.", "Pagination": {"StartPage": "83", "EndPage": "88", "MedlinePgn": "83-88"}, "Abstract": {"AbstractText": ["The purpose of this study was to investigate the safety and effects of Melissa officinalis, a good source of bioactive components, on apolipoprotein (Apo)B, Apo A-I, and their ratio, lipids ratios and intercellular adhesion molecule-1(ICAM-1) in patients with type 2 diabetes.", "For the present randomized, double-blinded, placebo-controlled clinical trial, 70 type 2 diabetic patients aged 20-65 years old were randomly assigned to receive hydroalcoholic extract of M. officinalis (HEMO) (700\u2009mg/d) or placebo twice-daily for 12 weeks.", "There were significant differences in serum Apo A-I, TC/ HDL-c and LDL-c/ HDL-c between the two groups at the end of the study (p\u2009<\u20090.05), but we did not show significant differences in the values for Apo B, Apo B/Apo A-I, TG/HDL-c, ICAM-1 and liver enzymes include AST, ALT, and ALP between the study groups. Although both groups showed a significant reduction in ICAM-1, AST and, ALP (p\u2009<\u20090.05), no significant differences in ICAM-1, AST and, ALP were observed. At end, in M. officinalis group, there was a significant increase in Apo A-I (p\u2009=\u20090.003) and significant reduction in TG/HDL-c (p\u2009=\u20090.05) compared with initial values, as well as in placebo group, there was a significant rising in Apo B/Apo A-I (p\u2009=\u20090.02) and significant reduction in Apo A-I (p\u2009=\u20090.001) compared with baseline values.", "M. officinalis is safe and effective in improvement of Apo A-I, Apo B/Apo A-I, and lipids ratios as key factors promoting cardiovascular disease (CVD) in type II diabetic patients."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research center for prevention of cardiovascular disease, Institute of Endocrinology & metabolism, Iran university of medical sciences, Tehran, Iran; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Asadi", "ForeName": "Akbar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research center for prevention of cardiovascular disease, Institute of Endocrinology & metabolism, Iran university of medical sciences, Tehran, Iran; Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran. Electronic address: shidfar.f@iums.ac.ir."}], "LastName": "Shidfar", "ForeName": "Farzad", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Safari", "ForeName": "Mostafa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research center for prevention of cardiovascular disease, Institute of Endocrinology & metabolism, Iran university of medical sciences, Tehran, Iran."}], "LastName": "Malek", "ForeName": "Mojtaba", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Statistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hosseini", "ForeName": "Agha Fateme", "Initials": "AF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}], "LastName": "Rezazadeh", "ForeName": "Shamsali", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Iranian Diabetes Association, Tehran, Iran."}], "LastName": "Rajab", "ForeName": "Asadollah", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Worcester Memorial Hospital, University of Massachusetts, Worcester, U.S.A."}], "LastName": "Shidfar", "ForeName": "Shahrzad", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, School of Pharmaceutical Chemistry, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran."}], "LastName": "Hosseini", "ForeName": "Sharieh", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Randomized Controlled Trial"]}, "MedlineJournalInfo": {"Country": "Scotland", "MedlineTA": "Complement Ther Med", "NlmUniqueID": "9308777", "ISSNLinking": "0965-2299"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "APOA1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Apolipoprotein A-I"}, {"RegistryNumber": "0", "NameOfSubstance": "Apolipoproteins B"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "126547-89-5", "NameOfSubstance": "Intercellular Adhesion Molecule-1"}], "MeshHeadingList": [{"QualifierName": ["blood"], "DescriptorName": "Apolipoprotein A-I"}, {"QualifierName": ["blood"], "DescriptorName": "Apolipoproteins B"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Intercellular Adhesion Molecule-1"}, {"QualifierName": ["blood"], "DescriptorName": "Lipids"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Melissa"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Plant Extracts"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "4", "Day": "18"}, {"Year": "2018", "Month": "7", "Day": "11"}, {"Year": "2018", "Month": "7", "Day": "30"}, {"Year": "2018", "Month": "9", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "9", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "3", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30219475", "10.1016/j.ctim.2018.07.015", "S0965-2299(18)30355-8"]}}]}